瑞銀全球生物科技基金(CNY)(停止銷售)
11.91離岸人民幣0(0%)
2017/06/01更新
績效 / 1月5.63%
3月6.22%
1年6.53%
晨星評等-
- 1.現金16.86%
- 2.股票1.93%
- 3.債券0.00%
- 4.其他81.21%
- 1.美國82.58%
- 2.歐洲不包含歐元區1.45%
- 3.歐元區0.48%
- 1.Celgene Corp8.21%
- 2.Amgen Inc6.61%
- 3.Gilead Sciences Inc5.89%
- 4.Biogen Inc5.11%
- 5.Vertex Pharmaceuticals Inc5.06%
- 6.Incyte Corp4.94%
- 7.AbbVie Inc4.18%
- 8.Biomarin Pharmaceutical Inc4.11%
- 9.Alkermes PLC3.10%
- 10.Regeneron Pharmaceuticals Inc2.74%
- 1.現金16.86%
- 2.股票1.93%
- 3.債券0.00%
- 4.其他81.21%
- 1.美國82.58%
- 2.歐洲不包含歐元區1.45%
- 3.歐元區0.48%
- 1.Celgene Corp8.21%
- 2.Amgen Inc6.61%
- 3.Gilead Sciences Inc5.89%
- 4.Biogen Inc5.11%
- 5.Vertex Pharmaceuticals Inc5.06%
- 6.Incyte Corp4.94%
- 7.AbbVie Inc4.18%
- 8.Biomarin Pharmaceutical Inc4.11%
- 9.Alkermes PLC3.10%
- 10.Regeneron Pharmaceuticals Inc2.74%